To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Total voting rights

Release Date: 01/03/2016 15:00
Code(s): MEI     PDF:  
Wrap Text
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88

TOTAL VOTING RIGHTS


In accordance with Disclosure and Transparency Rule 5.6.1R, as at 29 February 2016, the issued share capital and voting rights of Mediclinic International plc were as follows:
Class of shares in issue Ordinary shares of 10p each Number of ordinary shares in issue 737,243,810 Number of shares held in Treasury 0 Total nominal value of issued shares GBP 73,724,381 Total Voting Rights 737,243,810
The above total voting rights figure (737,243,810) may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in Mediclinic International plc under the FCA's Disclosure and Transparency Rules.
For the purpose of the Transparency Directive the Home Member State of the issuer is the United Kingdom. For and on behalf of Mediclinic International plc
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom Website: www.mediclinic.com
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Limited For further information, please contact:
Company Secretary - Capita Company Secretarial Services Limited Victoria Dalby +44 (0)207 954 9528 1 March 2016
Date: 01/03/2016 03:00:00 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story